Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function
- PMID: 21389245
- PMCID: PMC3700400
- DOI: 10.1523/JNEUROSCI.2212-10.2011
Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function
Abstract
Central administration of glucagon-like peptide-1 (GLP-1) causes a dose-dependent reduction in food intake, but the role of endogenous CNS GLP-1 in the regulation of energy balance remains unclear. Here, we tested the hypothesis that CNS GLP-1 activity is required for normal energy balance by using two independent methods to achieve chronic CNS GLP-1 loss of function in rats. Specifically, lentiviral-mediated expression of RNA interference was used to knock down nucleus of the solitary tract (NTS) preproglucagon (PPG), and chronic intracerebroventricular (ICV) infusion of the GLP-1 receptor (GLP-1r) antagonist exendin (9-39) (Ex9) was used to block CNS GLP-1r. NTS PPG knockdown caused hyperphagia and exacerbated high-fat diet (HFD)-induced fat accumulation and glucose intolerance. Moreover, in control virus-treated rats fed the HFD, NTS PPG expression levels correlated positively with fat mass. Chronic ICV Ex9 also caused hyperphagia; however, increased fat accumulation and glucose intolerance occurred regardless of diet. Collectively, these data provide the strongest evidence to date that CNS GLP-1 plays a physiologic role in the long-term regulation of energy balance. Moreover, they suggest that this role is distinct from that of circulating GLP-1 as a short-term satiation signal. Therefore, it may be possible to tailor GLP-1-based therapies for the prevention and/or treatment of obesity.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100001.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100002.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100003.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100004.gif)
![Figure 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100005.gif)
![Figure 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100006.gif)
![Figure 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3949425/bin/zns9991197100007.gif)
Similar articles
-
Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats.Physiol Behav. 2018 Aug 1;192:194-199. doi: 10.1016/j.physbeh.2018.03.037. Epub 2018 Apr 11. Physiol Behav. 2018. PMID: 29654813
-
Sensitivity to the satiating effects of exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats.Int J Obes (Lond). 2010 Sep;34(9):1427-33. doi: 10.1038/ijo.2010.78. Epub 2010 Apr 20. Int J Obes (Lond). 2010. PMID: 20404826 Free PMC article.
-
Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.Endocrinology. 2008 Oct;149(10):4768-77. doi: 10.1210/en.2008-0180. Epub 2008 Jun 12. Endocrinology. 2008. PMID: 18556349
-
A Role for GLP-1 in Treating Hyperphagia and Obesity.Endocrinology. 2020 Aug 1;161(8):bqaa093. doi: 10.1210/endocr/bqaa093. Endocrinology. 2020. PMID: 32516384 Free PMC article. Review.
-
PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.Am J Physiol Regul Integr Comp Physiol. 2015 Oct 15;309(8):R795-804. doi: 10.1152/ajpregu.00333.2015. Epub 2015 Aug 19. Am J Physiol Regul Integr Comp Physiol. 2015. PMID: 26290108 Free PMC article. Review.
Cited by
-
GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.J Clin Transl Endocrinol. 2024 Feb 29;35:100333. doi: 10.1016/j.jcte.2024.100333. eCollection 2024 Mar. J Clin Transl Endocrinol. 2024. PMID: 38449772 Free PMC article. Review.
-
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity.Endocr Rev. 2024 May 7;45(3):309-342. doi: 10.1210/endrev/bnad033. Endocr Rev. 2024. PMID: 38019584 Free PMC article. Review.
-
Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem.Cells. 2023 Jul 7;12(13):1801. doi: 10.3390/cells12131801. Cells. 2023. PMID: 37443835 Free PMC article. Review.
-
The role of glucagon-like peptide-1 (GLP-1) in fluid and food intakes in vasopressin-deficient Brattleboro rats.Physiol Behav. 2023 Apr 1;262:114093. doi: 10.1016/j.physbeh.2023.114093. Epub 2023 Jan 24. Physiol Behav. 2023. PMID: 36706972 Free PMC article.
-
The importance of estradiol for body weight regulation in women.Front Endocrinol (Lausanne). 2022 Nov 7;13:951186. doi: 10.3389/fendo.2022.951186. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36419765 Free PMC article. Review.
References
-
- Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157. - PubMed
-
- Bollheimer LC, Wrede CE, Rockmann F, Ottinger I, Schölmerich J, Buettner R. Glucagon production of the rat insulinoma cell line INS-1-A quantitative comparison with primary rat pancreatic islets. Biochem Biophys Res Commun. 2005;330:327–332. - PubMed
-
- Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–1772. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical